Wisecube

Wisecube

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.7M

Overview

Wisecube is a private AI/ML company providing a foundational graph AI platform tailored for life sciences R&D. Its technology integrates hundreds of biomedical data sources into a billion-scale knowledge graph (Orpheus) and employs predictive AI models to accelerate drug discovery tasks like target identification and safety prediction. The company operates a platform business model, selling its semantic AI and analytics software to biopharma and academic partners to enhance research efficiency and decision-making. Wisecube positions itself as a critical tool for data-driven medical research, helping organizations navigate the explosion of biomedical literature and unstructured data.

AI / Machine Learning

Technology Platform

Foundational Graph AI model and the Orpheus Knowledge Graph, which synthesizes hundreds of biomedical data sources (literature, clinical trials, chemical, protein databases) into a connected semantic network. It uses NLP and graph analytics to predict novel relationships and answer complex biomedical queries.

Funding History

2
Total raised:$1.7M
Grant$500K
Seed$1.2M

Opportunities

The platform addresses the critical industry pain points of soaring R&D costs, data overload, and the need for faster, data-driven decision-making.
The massive and growing global pharma R&D budget, coupled with the rapid adoption of AI/ML tools, presents a significant total addressable market for its software.

Risk Factors

Faces intense competition from other AI drug discovery platforms and large tech entrants.
Value is contingent on the accuracy of its predictions and adoption by a traditionally conservative biopharma industry.
Revenue depends on external R&D budgets, which can be cyclical.

Competitive Landscape

Highly competitive. Wisecube competes with pure-play AI discovery platforms (e.g., Exscientia, Insilico Medicine), large tech companies with life sciences divisions (e.g., Google/Isomorphic Labs, NVIDIA), and providers of scientific databases and informatics tools (e.g., Elsevier, Clarivate). Differentiation hinges on the depth and integration of its knowledge graph and the predictive power of its foundational graph AI models.